Skip to Content

Perrigo Company plc

Securities Class Action

  • Date:
  • 1/16/2026
  • Company Name:
  • Perrigo Company plc
  • Stock Symbol:
  • PRGO
  • Class Period:
  • FROM 2/27/2023 TO 11/4/2025
  • Status:
  • Filed
  • Filing Date:
  • 11/17/2025
  • Court:
  • U.S. District Court: Southern District of New York

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Perrigo Company plc (“Perrigo” or the “Company”) (NYSE:PRGO) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Perrigo securities between February 27, 2023 and November 4, 2025, both dates inclusive (the “Class Period”). Investors have until January 16, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

According to the complaint, during the class period, defendants failed to disclose: (1) that the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs; (2) that Perrigo needed to make substantial capital and operational expenditures above the Company's outwardly stated cost estimates to remediate the infant formula business; (3) that there were significant manufacturing deficiencies in the facility for the Company's infant formula business; and (4) that, as a result of the foregoing, the Company's financial results, including earnings and cash flow, were overstated.

Plaintiff alleges that on November 5, 2025, Perrigo announced disappointing financial results for the third quarter ended September 27, 2025. The press release revealed that Perrigo had slashed its fiscal year 2025 outlook "due primarily to infant formula industry dynamics." The same day, Perrigo issued a press release, announcing the Company "is initiating a strategic review of its infant formula business." The press release revealed Perrigo is "reassessing the Company's previously announced investment in this business of $240 million" and that the infant formula business had become "less strategic." On this news, Perrigo's stock price fell $5.09, or 25.2%, to close at $15.10 per share on November 5, 2025.

If you purchased or otherwise acquired Perrigo shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.
Contact Instructions
Please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com with any questions regarding the case.a
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Perrigo Company plc. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: